Consistent with our finding of an increased expression of the mentioned markers, similar changes in the AT expression of MyD88, IRAK1, and IRF5 have been reported in individuals with obesity and/or type-2 diabetes [33,45,66]. The gene discussed is MYD88; the disease is obesity due to melanocortin 4 receptor deficiency.